Publication

Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes

Journal Paper/Review - Dec 1, 2015

Units
PubMed
Doi

Citation
Schmied L, Stern M, Hess C, Meylan P, Manuel O, Villard J, Christoph B, Mueller N, Boggian K, Van Delden C, Garzoni C, Hirsch H, Schmitter K, Gonzalez A, Terszowski G. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes. Transplantation 2015; 99:2651-5.
Type
Journal Paper/Review (English)
Journal
Transplantation 2015; 99
Publication Date
Dec 1, 2015
Issn Electronic
1534-6080
Pages
2651-5
Brief description/objective

BACKGROUND
Natural killer cell function is regulated by inhibitory and activating killer cell immunoglobulin-like receptors (KIR). Previous studies have documented associations of KIR genotype with the risk of cytomegalovirus (CMV) replication after solid organ transplantation.

METHODS
In this study of 649 solid organ transplant recipients, followed prospectively for infectious disease events within the Swiss Transplant Cohort Study, we were interested to see if KIR genotype associated with virus infections other than CMV.

RESULT
We found that KIR B haplotypes (which have previously been linked to protection from CMV replication) were associated with protection from varicella zoster virus infection (hazard ratio, 0.43; 95% confidence interval, 0.21-0.91; P = 0.03). No significant associations were detected regarding the risk of herpes simplex, Epstein-Barr virus or BK polyomavirus infections.

CONCLUSIONS
In conclusion, these data provide evidence that the relative protection of KIR haplotype B from viral replication after solid organ transplantation may extend beyond CMV to other herpes viruses, such as varicella zoster virus and possibly Epstein-Barr virus.